Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Neurobiol Dis ; 74: 295-304, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25486547

RESUMO

Long-term administration of l-3,4-dihydroxyphenylalanine (levodopa), the mainstay treatment for Parkinson's disease (PD), is accompanied by fluctuations in its duration of action and motor complications (dyskinesia) that dramatically affect the quality of life of patients. Levodopa-induced dyskinesias (LID) can be modeled in rats with unilateral 6-OHDA lesions via chronic administration of levodopa, which causes increasingly severe axial, limb, and orofacial abnormal involuntary movements (AIMs) over time. In previous studies, we showed that the direct activation of CB1 cannabinoid receptors alleviated rat AIMs. Interestingly, elevation of the endocannabinoid anandamide by URB597 (URB), an inhibitor of endocannabinoid catabolism, produced an anti-dyskinetic response that was only partially mediated via CB1 receptors and required the concomitant blockade of transient receptor potential vanilloid type-1 (TRPV1) channels by capsazepine (CPZ) (Morgese et al., 2007). In this study, we showed that the stimulation of peroxisome proliferator-activated receptors (PPAR), a family of transcription factors activated by anandamide, contributes to the anti-dyskinetic effects of URB+CPZ, and that the direct activation of the PPARγ subtype by rosiglitazone (RGZ) alleviates levodopa-induced AIMs in 6-OHDA rats. AIM reduction was associated with an attenuation of levodopa-induced increase of dynorphin, zif-268, and of ERK phosphorylation in the denervated striatum. RGZ treatment did not decrease striatal levodopa and dopamine bioavailability, nor did it affect levodopa anti-parkinsonian activity. Collectively, these data indicate that PPARγ may represent a new pharmacological target for the treatment of LID.


Assuntos
Antidiscinéticos/farmacologia , Discinesia Induzida por Medicamentos/tratamento farmacológico , Levodopa/toxicidade , PPAR gama/agonistas , Transtornos Parkinsonianos/metabolismo , Tiazolidinedionas/farmacologia , Animais , Antidiscinéticos/farmacocinética , Antidiscinéticos/toxicidade , Corpo Estriado/efeitos dos fármacos , Corpo Estriado/metabolismo , Dopamina/metabolismo , Dinorfinas/metabolismo , Discinesia Induzida por Medicamentos/metabolismo , Proteína 1 de Resposta de Crescimento Precoce/metabolismo , MAP Quinases Reguladas por Sinal Extracelular/metabolismo , Levodopa/farmacocinética , Levodopa/farmacologia , Masculino , Oxidopamina , PPAR gama/metabolismo , Transtornos Parkinsonianos/tratamento farmacológico , Fosforilação/efeitos dos fármacos , Ratos Sprague-Dawley , Ratos Wistar , Rosiglitazona
2.
Hippocampus ; 17(3): 220-6, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17203462

RESUMO

Latent inhibition (LI), that is the decrease in conditioned response induced by the repeated nonreinforced pre-exposures to the to-be-conditioned stimulus, is disrupted by entorhinal cortex (EC) lesions. The mechanism involved in this disruption is unknown, and in particular the experimental stage (pre-exposure or conditioning) at which the integrity of EC is necessary has to be determined. The purpose of this study was to address this issue by using reversible inactivation of the EC by local micro-infusion of tetrodotoxin (TTX). TTX was infused either before the pre-exposure phase, before the conditioning phase, or before both phases. LI was unaffected in rats that received TTX before conditioning or before both pre-exposure and conditioning. In contrast, LI was disrupted in rats that received TTX before pre-exposure only. These results are discussed in the framework of LI models.


Assuntos
Condicionamento Psicológico/fisiologia , Córtex Entorrinal/fisiologia , Inibição Neural/fisiologia , Animais , Condicionamento Psicológico/efeitos dos fármacos , Emoções/efeitos dos fármacos , Emoções/fisiologia , Córtex Entorrinal/efeitos dos fármacos , Masculino , Modelos Neurológicos , Inibição Neural/efeitos dos fármacos , Ratos , Ratos Long-Evans , Bloqueadores dos Canais de Sódio/farmacologia , Canais de Sódio/efeitos dos fármacos , Canais de Sódio/metabolismo , Tetrodotoxina/farmacologia
3.
Hippocampus ; 16(2): 114-24, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16281294

RESUMO

Recent studies have shown that the integrity of the entorhinal cortex (EC) is not required for simple contextual conditioning. In background contextual conditioning, i.e., when a phasic cue is present during training, the involvement of the EC is still a matter of debate. Therefore, the present work further examines whether the EC is required for background contextual conditioning using a tone as the phasic cue. Rats sustaining either excitotoxic lesions of the EC or sham-lesions were trained with one of two procedures differing with respect to the predictive value of the tone: a paired procedure in which the tone perfectly predicts shock occurrence and overshadows context, and an unpaired procedure in which the predictive value of the tone is reduced. Conditioned fear was assessed by freezing responses during conditioning, reexposure to the training context, and reexposure to the tone in a new context. Postshock freezing was reduced in rats with entorhinal lesions. In all rats trained with the paired procedure, freezing to the context was low and freezing to the tone was high, suggesting that the tone has overshadowed the context during the conditioning session. The reverse pattern was observed with the unpaired procedure in sham-operated rats. In rats with entorhinal lesions trained with the unpaired procedure, freezing responses to the context was markedly reduced. In a new context, however, entorhinal-lesioned rats showed higher freezing scores than those of sham-lesioned rats. Freezing to the tone was unaffected by the lesion irrespective of the tone's predictive value. As a whole, these results support the notion that the EC is required for normal background contextual freezing.


Assuntos
Condicionamento Clássico/fisiologia , Córtex Entorrinal/fisiologia , Medo/fisiologia , Estimulação Acústica , Animais , Aprendizagem por Associação/fisiologia , Sinais (Psicologia) , Interpretação Estatística de Dados , Eletrochoque , Agonistas de Aminoácidos Excitatórios/toxicidade , Masculino , N-Metilaspartato/toxicidade , Ratos , Ratos Long-Evans
4.
Behav Pharmacol ; 16(1): 35-42, 2005 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-15706136

RESUMO

Dopamine release within the nucleus accumbens shell is suggested to control the salience of environmental stimuli, and previous research has shown that the indirect dopamine agonist D-amphetamine can alter the salience of both aversive and neutral stimuli. In experiment 1, the effect of systemic injection of D-amphetamine (0.5, 1 mg/kg) on fear conditioning to a tone was assessed in an 'off-baseline' conditioned suppression procedure using several footshock intensities. Although the effects of amphetamine on conditioning were unclear, the results indicated a deficit of simple tone habituation in amphetamine-treated rats. In experiment 2, habituation of the orienting reaction to a tone was assessed by the progressive reduction of lick suppression upon repeated presentation of the auditory stimulus. D-Amphetamine delayed tone habituation, whether administered systemically (0.5, 1 mg/kg) or into the nucleus accumbens shell (3, 10 microg/0.5 microl). These data are consistent with electrophysiological and neurochemical data demonstrating the role of nucleus accumbens dopamine in novelty processing. The relevance of the data to latent inhibition is discussed.


Assuntos
Estimulantes do Sistema Nervoso Central/farmacologia , Dextroanfetamina/farmacologia , Habituação Psicofisiológica/efeitos dos fármacos , Núcleo Accumbens , Estimulação Acústica , Animais , Estimulantes do Sistema Nervoso Central/administração & dosagem , Condicionamento Psicológico/efeitos dos fármacos , Dextroanfetamina/administração & dosagem , Extinção Psicológica/efeitos dos fármacos , Medo/efeitos dos fármacos , Injeções Intraperitoneais , Masculino , Microinjeções , Ratos , Ratos Long-Evans
5.
Neuropharmacology ; 45(2): 190-200, 2003 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12842125

RESUMO

Lesions of the entorhinal cortex are now an accepted model for mimicking some of the neuropathological aspects of schizophrenia, since evidence has accumulated for the presence of cytoarchitectonic abnormalities within this cortex in schizophrenic patients. The present study was undertaken to address the functional consequences of bilateral entorhinal cortex lesions on antipsychotic-induced c-fos expression. After a 15-day recovery period, the effect of a typical antipsychotic, haloperidol (1 mg/kg), on c-fos mRNA expression was compared with that of an atypical one, olanzapine (10 mg/kg), in both sham-lesioned and entorhinal cortex-lesioned rats. In sham-lesioned rats, both haloperidol and olanzapine induced c-fos expression in the caudal cingulate cortex, dorsomedial and dorsolateral caudate-putamen, nucleus accumbens core and shell and lateral septum. In addition, olanzapine, but not haloperidol, increased c-fos expression within the central amygdala. In entorhinal cortex-lesioned rats, haloperidol-induced c-fos expression was markedly reduced in most areas. In contrast, the olanzapine-induced c-fos expression was not altered in the nucleus accumbens shell and lateral septum of the lesioned rats. These findings reveal that entorhinal cortex lesions affect c-fos expression in a compound- and regional-dependent manner. Our results further emphasize the importance of the exploration of the mechanisms of action of antipsychotic drugs in the context of an associated cortical pathology.


Assuntos
Córtex Entorrinal/efeitos dos fármacos , Genes fos/efeitos dos fármacos , Haloperidol/farmacologia , Pirenzepina/análogos & derivados , Pirenzepina/farmacologia , Prosencéfalo/efeitos dos fármacos , Animais , Benzodiazepinas , Córtex Entorrinal/metabolismo , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/fisiologia , Genes fos/fisiologia , Masculino , Olanzapina , Prosencéfalo/metabolismo , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Ratos , Ratos Long-Evans
6.
Psychol Rep ; 88(1): 111-4, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11293017

RESUMO

This study investigated the prevalence of psychoaffective immaturity and tested the hypothesis that it associated with bad prognosis. For 135 psychiatric patients meeting criteria for personality, neurotic, affective, substance use, or psychotic disorders emotional immaturity was rated using the 1985 diagnostic criteria of Doutheau, Dubertret, Moutin, and Barrois. 58 subjects (42.96%, 95% Confidence Interval: 34.61-51.31) were classified as immature. Scores of the Nonimmature and Immature groups were compared for the Beck Depression Inventory and the Professional and Social Functioning Assessment Scale. Scores were, respectively, significantly higher and lower in those patients classified as Immature than those who were classified Nonimmature. When depression was controlled by a covariance analysis, the mean difference on the Professional and Social Functioning Assessment Scale remained significant. It appears that psychoaffective immaturity is a factor associated with severity of psychiatric disorders.


Assuntos
Afeto , Transtornos Mentais/psicologia , Transtornos da Personalidade/psicologia , Socialização , Adulto , Feminino , Previsões , Humanos , Masculino , Transtornos Mentais/complicações , Pessoa de Meia-Idade , Transtornos da Personalidade/complicações , Transtornos da Personalidade/epidemiologia , Prevalência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...